791775-01-4 Usage
Uses
Used in Pharmaceutical Synthesis:
Ethyl 3-azetidine carboxylate is used as an intermediate for the synthesis of various pharmaceuticals, leveraging its unique four-membered ring structure to create novel compounds with potential therapeutic applications.
Used in Agrochemical Synthesis:
In the agrochemical industry, Ethyl 3-azetidine carboxylate is employed as an intermediate, contributing to the development of new agrochemicals that can enhance crop protection and yield.
Used as a Chiral Auxiliary in Asymmetric Synthesis:
Ethyl 3-azetidine carboxylate is utilized as a chiral auxiliary in asymmetric synthesis, aiding in the production of enantiomerically pure compounds, which are crucial for the pharmaceutical and chemical industries due to their specific biological activities.
Used in the Development of Anti-inflammatory Agents:
The derivatives of Ethyl 3-azetidine carboxylate have shown anti-inflammatory properties, making it a valuable compound in the development of new anti-inflammatory drugs.
Used in the Development of Anti-cancer Agents:
Given the potential anti-cancer properties of its derivatives, Ethyl 3-azetidine carboxylate plays a significant role in the research and development of novel anti-cancer therapeutics.
Check Digit Verification of cas no
The CAS Registry Mumber 791775-01-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,1,7,7 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 791775-01:
(8*7)+(7*9)+(6*1)+(5*7)+(4*7)+(3*5)+(2*0)+(1*1)=204
204 % 10 = 4
So 791775-01-4 is a valid CAS Registry Number.
791775-01-4Relevant academic research and scientific papers
IMIDAZO [4, 5 -C] PYRIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
-
Paragraph 0034, (2013/08/28)
Novel imidazolopyridines according to Formula I, able to inhibit JAK are disclosed, wherein R1 and Cy are as disclosed herein. These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
BENZAMIDINE DERIVATIVES SUBSTITUTED BY CYCLIC AMINO ACID AND CYCLIC HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS
-
, (2008/06/13)
This invention is directed to benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
